109184-85-2

Basic information

• Product Name: Ethanamine, N,N-diethyl-2-(2-methoxy-4-nitrophenoxy)-
• CAS NO: 109184-85-2
• Molecular Formula: C13H20N2O4
• Molecular Weight: 268.313
• Mol File: 109184-85-2.mol

Chemical Properties

• CAS DataBase Reference: Ethanamine, N,N-diethyl-2-(2-methoxy-4-nitrophenoxy)-(CAS DataBase Reference)
• NIST Chemistry Reference: Ethanamine, N,N-diethyl-2-(2-methoxy-4-nitrophenoxy)-(109184-85-2)
• EPA Substance Registry System: Ethanamine, N,N-diethyl-2-(2-methoxy-4-nitrophenoxy)-(109184-85-2)

Safety Data

• Hazardous Substances Data: 109184-85-2(Hazardous Substances Data)

Upstream product

• 100200-99-5 potassium 2-methoxy-4-nitrophenolate monohydrate 
• 100-35-6 2-(diethylamino)ethyl chloride 
• 3251-56-7 2-methoxy-4-nitrophenol 
• 869-24-9 2-chloro-N,N-diethylethylamine hydrochloride 
• 100-37-8 2-(Diethylamino)ethanol 

Downstream Products

• 96729-89-4 4-(2-(diethylamino)ethoxy)-3-methoxybenzamine 
• 917563-48-5 [4-(2-diethylamino-ethoxy)-3-methoxy-phenyl]-ethyl-amine 

Relevant articles and documents

Design, synthesis, and biological evaluation of pyrimidine-2-carboxamide analogs: Investigation for novel RAGE inhibitors with reduced hydrophobicity and toxicity

This paper describes an investigation of novel RAGE inhibitors with improved drug-like properties. To identify the improved drug-like RAGE inhibitor, we designed and synthesized pyrimidine-2-carboxamide analogs based on our previous work. Several potent a

Novel heteroarylcarboxamide derivative or pharmacutically acceptable salt thereof, process for the preparation thereof and pharmaceutical composition for prevention or treatment of RAGE receptor related diseases containing the same as an active ingredient

The present invention refers to novel heterocyclic biting Carbox probably the id derivative acceptable salt, and manufacturing method thereof including RAGE associated active acetylcholinesterase receptor or pharmaceutical composition for preventing or treating disease is directed to. Heterocycle by the present invention a derivative biting Carbox probably the id RAGE receptor antagonism in by, nerve cells with the beta loss oh with wheat id RAGE conjunction with receptor, inhibiting moving into brain, the resulting beta Amyloid plaque formed 21 is known to effectively inhibit generation.. Furthermore, memory a chemicals that are important in the acetylcholine for decomposing an aromatic thus inhibiting acetylcholine s reel sacrifice , RAGE disease associated active acetylcholinesterase receptor or Alzheimer's disease, cerebrovascular dementia, dementia due to damage bean curd, multi blockade dementia, Alzheimer's disease or the like dementia alcoholic or mixed dementia multi blockade and including dementia, pick (pick) bottle, a smartcrew [...] -Jakob (Creutzfeldt-jakob) bottle, that thyroid gland symptoms , bean curd a blade Parkinson (Parkinson) bottle, Huntington's disease (Huntington) which is useful in preventing or treating, can be used.

SAR of biphenyl carboxamide ligands of the human melanin-concentrating hormone receptor 1 (MCH R1): Discovery of antagonist SB-568849

We report here the discovery of a class of MCH R1 ligands based on a biphenyl carboxamide template. A docked-in model is presented indicating key interactions in the putative binding site of the receptor. Parallel high throughput synthetic techniques were

NOVEL AMIDE COMPOUNDS WITH MCH ANTAGONISTIC EFFECT AND MEDICAMENTS COMPRISING SAID COMPOUNDS

The invention relates to amide compounds of general formula (I), in which the groups and residues A, B, b, W, X, Y, Z, R1, R2 and R3 have the meanings given in claim 1. The invention further relates to medicaments comprising at least one of said amides. Said medicaments are suitable for the treatment of metabolic disorders and/or eating disorders, in particular, obesity, bulimia, anorexia, hyperphagia, and diabetes as a result of the MCH receptor antagonism.